Search Results 1-10 of 18614 for intestinal metaplasia

1. Examining the impact of endoscopic resection approach on intestinal metaplasia and dysplasia recurrence after complete remission: EMR versus ESD - Mayo Clinic

   Mayo Clinic researchers have previously demonstrated that both ER approaches yield comparable rates of complete remission of intestinal metaplasia (CRIM).

2. Gastrointestinal Neoplasia Clinic - Overview

   Gastrointestinal stromal tumors (GISTs); Gastric intestinal metaplasia; Lymphoma of colon or rectum; Melanoma of the GI tract; Uncommon neoplasms of the stomach ...

3. GI Cancer Clinic - Mayo Clinic Healthcare

   Known or suspected gastrointestinal cancers, such as stomach, small bowel, colon or rectal cancer. ... Gastric intestinal metaplasia. Lymphoma of colon or rectum.

4. Digestive Diseases News - Medical Professionals - Mayo Clinic

   Examining the impact of endoscopic resection approach on intestinal metaplasia and dysplasia recurrence after complete remission: EMR versus ESD. Endoscopic ...

5. Barrett's esophagus - Symptoms and causes - Mayo Clinic

   Frequent heartburn and regurgitation of stomach contents; Difficulty swallowing food; Less commonly, chest pain. Curiously, approximately half of the people ...

6. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

   This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

7. Barrett's Esophagus Clinical Trials - Mayo Clinic Research

   This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

8. Optimizing surveillance in patients with dysplastic Barrett esophagus after endoscopic eradication - Mayo Clinic

   Recurrence of intestinal metaplasia and dysplasia after complete endoscopic eradication therapy (EET) of dysplasia or early adenocarcinoma is well documented.

9. Barrett's Esophagus Clinical Trials - Mayo Clinic Research

   This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

10. Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation? - Mayo Clinic

    ... intestinal metaplasia following endoscopic ablation. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...